Product

About MiEMPA-M 12.5/500 Tablets

MiEMPA-M 12.5/500 combines Empagliflozin and Metformin Hydrochloride, two powerful medications used in the management of Type 2 Diabetes. This combination therapy helps to reduce blood glucose levels by addressing the condition from multiple mechanisms.

Empagliflozin, an SGLT2 inhibitor, works by blocking the sodium-glucose transporter 2 (SGLT2) in the kidneys, which reduces glucose reabsorption. This leads to increased glucose excretion through urine and lower blood glucose levels. It also has cardiovascular benefits, as it helps to reduce the risk of cardiovascular events in Type 2 diabetes patients.

Metformin, on the other hand, works by improving insulin sensitivity and reducing hepatic glucose production. It is a well-known and widely prescribed medication in the management of Type 2 Diabetes. By combining Empagliflozin with Metformin, MiEMPA-M offers a comprehensive treatment to control blood sugar effectively.

This combination treatment is ideal for patients who have not achieved adequate glycemic control with diet and exercise alone, or for those who need additional support to manage their diabetes effectively. It not only helps to control blood sugar levels but also may provide added cardiovascular benefits.

Like all medications, MiEMPA-M 12.5/500 may cause side effects, such as urinary tract infections, dehydration, or gastrointestinal discomfort. Patients should consult their healthcare provider before starting the medication to ensure it is appropriate for their condition.

About MiEMPA-M 12.5/1000 Tablets

MiEMPA-M 12.5/1000 combines Empagliflozin and Metformin Hydrochloride in a higher dose to offer better glycemic control for Type 2 diabetes patients who need more intensive therapy. The combination of these two medications provides a comprehensive solution to help control blood sugar and reduce the risk of diabetes-related complications.

Empagliflozin is an SGLT2 inhibitor that helps the kidneys eliminate excess glucose through urine. It not only lowers blood sugar but also has cardiovascular benefits, making it especially helpful for diabetic patients at risk of heart-related issues.

Metformin, a cornerstone of Type 2 diabetes treatment, works by enhancing the body’s insulin sensitivity and decreasing glucose production by the liver. This makes it one of the most effective medications for controlling blood glucose levels over the long term.

This combination treatment is ideal for patients who have higher blood sugar levels and need a stronger approach. By combining both medications, MiEMPA-M 12.5/1000 provides a potent solution for achieving better blood glucose management and improving overall health.

Potential side effects of MiEMPA-M 12.5/1000 include dehydration, urinary tract infections, and gastrointestinal upset. It’s essential to follow the prescribed dose and consult with a healthcare provider for appropriate use.

About MIEMPA-L 10/5 Tablets

MIEMPA-L 10/5 is a combination of two highly effective medications: Empagliflozin and Linagliptin. Empagliflozin is an SGLT2 inhibitor, which helps reduce blood sugar by blocking glucose reabsorption in the kidneys and promoting glucose excretion through urine. Linagliptin is a DPP-4 inhibitor that increases insulin secretion in response to meals and decreases glucose production in the liver.

This combination therapy is particularly beneficial for Type 2 diabetes patients who require additional help in managing their blood glucose levels. By targeting multiple pathways, this treatment offers enhanced glycemic control while also providing cardiovascular benefits.

MIEMPA-L 10/5 tablets offer an effective solution for patients with Type 2 diabetes who are inadequately controlled with diet and exercise alone. It works by improving insulin sensitivity, increasing glucose excretion, and regulating blood sugar levels throughout the day.

Like all medications, MIEMPA-L 10/5 may cause side effects such as dizziness, gastrointestinal disturbances, or low blood pressure. Always consult your healthcare provider to ensure it's the right treatment for your condition.

About MIEMPA-L 25/5 Tablets

MIEMPA-L 25/5 is a combination of two effective medications: Empagliflozin and Linagliptin. This formulation is designed for patients with Type 2 diabetes who need enhanced glycemic control. Empagliflozin works by inhibiting the sodium-glucose cotransporter 2 (SGLT2) in the kidneys, which leads to increased glucose excretion through urine. Linagliptin, a DPP-4 inhibitor, helps to improve insulin secretion in response to meals and decreases glucose production in the liver.

This combination therapy is beneficial for patients who require more effective control of blood sugar levels, especially in cases where other medications may not provide sufficient results. Empagliflozin contributes to lowering blood sugar, while Linagliptin supports the body’s natural insulin response. Together, these medications provide a comprehensive approach to managing Type 2 diabetes and may also help reduce the risk of cardiovascular complications.

MIEMPA-L 25/5 tablets offer convenience by combining two drugs into a single tablet, simplifying the treatment regimen. This product is ideal for patients who need to improve their blood glucose management and want to benefit from a dual-action mechanism of action. MIEMPA-L 25/5 is typically used in conjunction with diet and exercise to improve glycemic control.

Potential side effects of MIEMPA-L 25/5 include dehydration, urinary tract infections, and gastrointestinal symptoms such as nausea or diarrhea. Patients should follow their healthcare provider’s advice and adjust the medication regimen if necessary.

About LINAGLY-M 2.5/850 Tablets

LINAGLY-M 2.5/850 combines two important medications used in the treatment of Type 2 Diabetes Mellitus: Linagliptin and Metformin Hydrochloride. This combination helps to manage blood sugar levels effectively in patients who cannot achieve sufficient control through diet and exercise alone. Linagliptin belongs to a class of medications known as DPP-4 inhibitors, while Metformin is a well-established drug that improves insulin sensitivity.

Linagliptin works by inhibiting the enzyme DPP-4, which plays a role in the breakdown of incretin hormones. These hormones help regulate insulin production in response to food intake. By preventing the breakdown of these hormones, Linagliptin enhances insulin secretion and reduces blood sugar levels.

Metformin works by decreasing the amount of sugar produced by the liver and improving the body's response to insulin. It helps reduce the amount of sugar absorbed from the intestines and increases insulin sensitivity in muscle and fat tissues. Together, these drugs provide a synergistic effect to better control blood sugar levels.

LINAGLY-M 2.5/850 tablets are particularly useful for patients who have been diagnosed with Type 2 diabetes and have not responded adequately to single-agent therapy. The combination of these two drugs provides a more comprehensive approach to managing the disease, improving both short-term and long-term outcomes.

Common side effects may include gastrointestinal discomfort, such as nausea or diarrhea. As with all medications, it is important to follow the prescribed dosage and consult with your healthcare provider if you experience any side effects or unusual symptoms.

About Metoprolol Succinate (ER) & Amlodipine Tablets METOEASE-AM XL 25

Metoprolol Succinate (extended-release) is a beta-blocker used to treat high blood pressure, angina, and heart failure. It works by blocking the effects of adrenaline on the heart, reducing the heart rate and blood pressure, and improving blood flow.

Amlodipine is a calcium channel blocker that helps to relax the blood vessels, reducing blood pressure and improving the heart's ability to pump blood. Together, these two medications are highly effective in managing hypertension and angina, as they both work in complementary ways to reduce the strain on the heart.

This combination medication, **METOEASE-AM XL 25**, is particularly useful for individuals with high blood pressure who also suffer from angina or have a history of heart disease. By combining Metoprolol Succinate and Amlodipine in one extended-release formulation, it helps maintain a stable blood pressure throughout the day while preventing chest pain (angina).

**METOEASE-AM XL 25** is typically taken once daily due to its extended-release formulation, providing 24-hour blood pressure control. It is important to follow the prescribed dosage and avoid missing doses to maintain consistent blood pressure control. This medication can be taken with or without food, and it should be swallowed whole, not crushed or chewed.

Common side effects include dizziness, fatigue, swelling of the ankles, or flushing. If you experience any severe side effects such as shortness of breath, chest pain, or fainting, seek medical attention immediately. As with any medication, it is important to have regular follow-up visits with your healthcare provider to monitor your response to treatment.

Before starting **METOEASE-AM XL 25**, it is essential to consult with your healthcare provider, especially if you have a history of heart disease, kidney problems, or other conditions that may require dose adjustments. Additionally, patients who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and benefits with their doctor.

Along with taking the medication, it is recommended to adopt a heart-healthy lifestyle, including regular exercise, a balanced diet, and avoiding smoking and excessive alcohol intake, to help manage high blood pressure and reduce the risk of heart-related complications.

About Telmisartan 40 mg and Amlodipine 5 mg Tablets IP TM Teleflex-AM 40 mg + 5 mg Tablets

Teleflex-AM 40 mg + 5 mg is a combination medication used to manage high blood pressure (hypertension). It contains two active ingredients: Telmisartan and Amlodipine, which work together to lower blood pressure and reduce the risk of heart disease and stroke.

Telmisartan is an angiotensin II receptor blocker (ARB), which works by relaxing blood vessels and preventing the narrowing of blood vessels that can occur due to high levels of angiotensin II, a hormone that can raise blood pressure. This helps lower blood pressure and makes it easier for the heart to pump blood.

Amlodipine is a calcium channel blocker that helps to relax and widen blood vessels, further reducing blood pressure. By working together, these two medications provide a more effective approach to managing hypertension, especially for patients who need a combination therapy for optimal blood pressure control.

This combination therapy is typically prescribed for patients whose blood pressure is not adequately controlled with a single medication. It helps reduce the risks associated with uncontrolled hypertension, such as heart failure, stroke, and kidney problems. Teleflex-AM 40 mg + 5 mg is commonly used in adults and should be taken as part of a comprehensive approach to managing high blood pressure, which may also include lifestyle changes such as diet, exercise, and weight management.

Common side effects may include dizziness, swelling of the feet or ankles, and fatigue. Serious side effects are rare but can include allergic reactions or severe drops in blood pressure. Patients should monitor their blood pressure regularly and follow their healthcare provider’s recommendations.

Before starting this combination therapy, it is important to consult with a healthcare provider to ensure that it is the right treatment for your condition, particularly if you have kidney disease, liver disease, or a history of heart conditions.

About Orlistat Capsules USP 60 mg TM l M Obelow-60 Capsules

Orlistat 60 mg is an over-the-counter medication used in the management of obesity. It works by inhibiting the enzyme lipase, which is responsible for breaking down dietary fats in the gastrointestinal tract. By blocking the absorption of fat from the diet, Orlistat helps reduce calorie intake and promotes weight loss.

This product is typically used in conjunction with a reduced-calorie diet and regular physical activity to help patients lose weight and maintain a healthy weight. It is recommended for individuals who are overweight or obese, especially those who are struggling with weight-related health issues such as high blood pressure, diabetes, or high cholesterol.

Orlistat is effective for reducing fat absorption by approximately 25%. However, to achieve the best results, it is important to follow a balanced diet, engage in regular exercise, and avoid high-fat meals that could cause unpleasant side effects, such as diarrhea and abdominal discomfort. While Orlistat helps promote fat loss, it is not a magic pill and requires lifestyle changes for sustainable results.

Common side effects include gastrointestinal issues, including oily stools, flatulence, and urgency to have a bowel movement. These side effects are generally mild and temporary but can be minimized by following a low-fat diet while using Orlistat.

As with any medication, it's important to consult with a healthcare provider before starting Orlistat to ensure it's appropriate for your weight loss goals and overall health condition.

About Orlistat Capsules USP 120 mg TM l M Obelow-120 Capsules

Orlistat 120 mg is a prescription medication used to aid in the management of obesity and to help reduce weight. It works by blocking the action of lipase, an enzyme that breaks down fats in the digestive system. By inhibiting fat absorption, Orlistat helps to reduce the total calorie intake, leading to weight loss.

This stronger dose of Orlistat is generally recommended for individuals who have more significant weight loss goals or who need a higher level of intervention to help manage obesity-related health risks. It is typically prescribed in conjunction with a reduced-calorie, low-fat diet and regular physical activity to maximize the results of weight loss efforts.

Orlistat is known to reduce fat absorption by approximately 30%, which can result in a significant reduction in body weight when used as part of a comprehensive weight loss program. However, the effectiveness of the drug is dependent on the patient’s adherence to diet and lifestyle changes.

Patients using Orlistat 120 mg should be mindful of their fat intake, as consuming high-fat meals can cause gastrointestinal side effects such as diarrhea, flatulence, and abdominal discomfort. These side effects are typically mild but can be minimized by following a healthy diet and avoiding high-fat foods.

Before starting Orlistat, it is important to consult with a healthcare provider to determine if this medication is appropriate based on your health condition and weight loss goals. Orlistat 120 mg should only be used under the supervision of a healthcare professional.

About Rosuvastatin Tablets I.P. ROSUDOSE 20

Rosuvastatin 20 mg (brand name: ROSUDOSE 20) is a medication used to lower cholesterol and reduce the risk of cardiovascular diseases such as heart attacks, strokes, and other heart-related issues. Rosuvastatin belongs to a class of drugs called statins, which work by inhibiting an enzyme in the liver responsible for producing cholesterol, ultimately lowering levels of low-density lipoprotein (LDL) or "bad" cholesterol.

This medication is commonly prescribed to patients with high cholesterol or those who are at risk of developing cardiovascular diseases due to factors such as high blood pressure, diabetes, smoking, or a family history of heart disease. Rosuvastatin helps to improve the balance between "good" high-density lipoprotein (HDL) cholesterol and "bad" LDL cholesterol, reducing the overall risk of heart disease.

Rosuvastatin 20 mg is typically taken once daily, with or without food. The dosage may be adjusted based on the patient's cholesterol levels and overall response to treatment. It is important to follow the prescribed dosage and maintain regular follow-ups with your healthcare provider to monitor your cholesterol levels and assess the effectiveness of the treatment.

Common side effects may include muscle pain, weakness, or stomach discomfort. These side effects are typically mild, but in rare cases, statins like Rosuvastatin can cause more severe muscle-related problems or liver damage. It is essential to report any unusual symptoms to your healthcare provider promptly. Additionally, patients should inform their doctor of any other medications they are taking, as Rosuvastatin may interact with other drugs.

Before starting Rosuvastatin, it is crucial to consult with a healthcare provider to determine if this medication is appropriate for your condition, especially if you have a history of liver problems, kidney disease, or if you are pregnant or breastfeeding.

About Epalrestat Sustained Release Tablets 150 mg - ΕΡΑΚΙΝΕ - 150

Epalrestat 150 mg (brand name: ΕΡΑΚΙΝΕ - 150) is a medication used to manage diabetic neuropathy, a condition that results in nerve damage caused by prolonged high blood sugar levels in people with diabetes. Epalrestat belongs to a class of drugs known as aldose reductase inhibitors and works by blocking the enzyme aldose reductase, which is responsible for the conversion of glucose to sorbitol. This process contributes to nerve damage in diabetic patients, and by inhibiting this enzyme, Epalrestat helps to reduce the symptoms and progression of neuropathy.

This medication is typically prescribed for patients with Type 1 or Type 2 diabetes who are experiencing nerve damage symptoms, including pain, tingling, and numbness in the hands and feet. By reducing the accumulation of sorbitol in nerve tissues, Epalrestat can help alleviate the discomfort associated with diabetic neuropathy, improving the patient's quality of life.

**Epalrestat Sustained Release Tablets 150 mg** is designed to provide a slow, consistent release of the medication over time, helping to maintain steady blood levels of the drug throughout the day. This sustained release formulation allows for improved patient compliance and fewer doses compared to immediate-release forms of the medication.

Common side effects of Epalrestat include gastrointestinal discomfort such as nausea or abdominal pain. These effects are typically mild and transient, but patients should contact their healthcare provider if they experience persistent or severe symptoms. As with any medication, it is essential to monitor blood sugar levels and follow the healthcare provider's instructions to manage both the neuropathy and the underlying diabetes effectively.

Before starting Epalrestat, it is important to consult with a healthcare provider to ensure it is the right treatment for your condition. It should be used in conjunction with proper blood sugar management through diet, exercise, and possibly other medications to control diabetes and reduce the risk of further complications.

About Pregabalin with Methylcobalamin Tablets Isogaba-M

Pregabalin is an anticonvulsant and neuropathic pain medication, while Methylcobalamin is a form of vitamin B12. Together in the formulation of **Isogaba-M**, they work synergistically to provide effective treatment for various types of nerve pain, including diabetic neuropathy, post-herpetic neuralgia (pain following shingles), and fibromyalgia.

Pregabalin helps to reduce the release of certain neurotransmitters that transmit pain signals in the brain and nervous system. By modifying the way the brain processes pain signals, Pregabalin is effective in treating nerve pain and anxiety. In addition, it is used to manage certain types of seizures in patients with epilepsy.

Methylcobalamin, a form of vitamin B12, plays an essential role in the maintenance of nerve health and function. It helps to regenerate nerve cells and reduce symptoms of nerve damage, which is especially beneficial in conditions like neuropathy, where nerve damage occurs due to diabetes or other causes.

This combination of Pregabalin with Methylcobalamin is commonly prescribed to manage pain and discomfort associated with diabetic neuropathy, sciatica, and other nerve-related issues. It is typically taken once or twice a day, as directed by a healthcare provider, and the dosage may vary depending on the severity of the condition being treated.

Common side effects include dizziness, drowsiness, or fatigue. In rare cases, patients may experience swelling, difficulty concentrating, or blurred vision. If any of these symptoms become persistent or severe, it is important to consult with a healthcare provider.

Before starting **Isogaba-M**, patients should consult their doctor, especially if they have a history of kidney problems, heart conditions, or a history of alcohol use disorder. This medication is also not recommended for pregnant or breastfeeding women without first consulting a healthcare provider.

It's essential to follow the prescribed dosage and avoid abruptly stopping the medication without a doctor's supervision to minimize the risk of withdrawal symptoms or other complications. Along with medication, patients should also adopt a healthy lifestyle that includes proper diet, exercise, and managing underlying health conditions such as diabetes to help manage nerve-related pain effectively.

About Sodium Alendronate Tablets IP Alenfos-70

Sodium Alendronate 70 mg (brand name: Alenfos-70) is a medication used to treat and prevent osteoporosis, a condition in which bones become weak and brittle. Osteoporosis is common in postmenopausal women and elderly individuals, and Alendronate helps to increase bone density, reducing the risk of fractures.

Alenfos-70 belongs to a class of drugs known as bisphosphonates, which work by inhibiting osteoclast activity, the cells responsible for breaking down bone tissue. By reducing bone resorption, Alendronate increases the strength of bones and reduces the risk of fractures associated with osteoporosis, particularly in the spine, hip, and wrist.

This medication is typically prescribed to patients with osteoporosis who are at risk of fractures. It may also be used to treat Paget’s disease of bone, a condition that causes abnormal bone growth. Alenfos-70 is usually taken once a week, with the dose being 70 mg per week. It is important to take the medication as directed to achieve the best results.

**Alenfos-70** should be taken on an empty stomach, first thing in the morning, with a full glass of water. Patients should remain upright for at least 30 minutes after taking the tablet to ensure proper absorption and avoid irritation of the esophagus. It is essential to avoid eating, drinking, or taking any other medications during this time to ensure maximum absorption of the drug.

Common side effects may include gastrointestinal discomfort such as heartburn, nausea, or stomach pain. These side effects are generally mild, but in rare cases, more serious effects such as esophageal irritation or bone, joint, or muscle pain may occur. If you experience any unusual symptoms, it is important to contact your healthcare provider promptly.

Before starting Sodium Alendronate, it is important to consult with a healthcare provider to determine if this medication is right for you, especially if you have any history of kidney disease, low calcium levels, or digestive issues. Regular monitoring and a healthy lifestyle, including calcium and vitamin D supplementation, are also recommended for optimal bone health.